Switzerland

Biotechnology firm Cytos is to link up with US pharmaceutical giant Pfizer in the development of vaccines for a number of human diseases, the Swiss firm announced on August 15 2008.... 2008-08-21

Strong growth in Central and Eastern Europe (CEE) for Sandoz, Novartis' generics division, has made a significant contribution to the generics company's H108 results. In US dollar... 2008-07-24

In a deal that could blow the rest of 2008's pharmaceutical acquisitions out of the water, Swiss drugmaker Roche has offered to buy the remaining shares US biotechnology giant Genentech... 2008-07-22

Swiss biopharmaceuticals firm Actelion has secured a lucrative licensing deal with GlaxoSmithKline (GSK) for its insomnia candidate almorexant. In return for worldwide marketing rights... 2008-07-15

Swiss firm Novartis has purchased 74mn shares of Alcon Laboratories from its parent company Nestle.

Swiss drugmaker Novartis looks set to take over fellow domestic player and long-standing research partner Speedel in a deal worth a potential US$880mn. On July 10 2008 Novartis, which... 2008-07-11

Following a negative appraisal from the UK's National Institute for Health and Clinical Excellence (NICE), Roche is to lower the price of its non-small cell lung cancer treatment... 2008-07-09

The first approval of Swiss firm Basilea Pharmaceutica's anti-infective, Zeftera (ceftobiprole), has once again highlighted the differences in regulatory agencies. After reviewing... 2008-07-02

In an effort to slow the decline in Tamiflu (oseltamivir) sales, Roche is to initiate a new corporate purchasing plan aimed at US businesses. Under the terms of the plan, firms will... 2008-07-01

In keeping with Roche's commitment to developing cancer therapies, the company has acquired worldwide exclusive rights to an early stage cancer therapy that is being co-developed... 2008-06-24